Inventor · disambiguated record
Sebastian Meier-Ewert
Also filed as: MEIER-EWERT SEBASTIAN
5 granted patents·5 pending applications·39 citations·filing 2000–2025
72Inventor score
Top patents by PatentIndex Score
10 records- 0186US6664048B1Identification and characterization of interacting moleculesMAX PLANCK GES ZUR FURDERUNG D·Filed 2000·Granted Dec 16, 2003·36 cites·47 claims
- 0271US2025084076A1Heterocyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 0371US2025101015A1Heterocyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 0464US2025340886A1Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereofIOMX THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 0562US12139480B25-thiazolecarboxamide kinase inhibitor and uses thereofIOMX THERAPEUTICS AG·Filed 2019·Granted Nov 12, 2024·0 cites·18 claims
- 0657US2021379067A1Dasatinib and another 5-thiazolecarboxamide kinase inhibitor, and uses thereofIOMX THERAPEUTICS AG·Filed 2019·Application pending·0 cites
- 0751US12172993B2Heterocyclic kinase inhibitors and uses thereofIOMX THERAPEUTICS AG·Filed 2019·Granted Dec 24, 2024·0 cites·53 claims
- 0850US6905818B1Method for the identification and characterization of interacting molecules by automated interaction matingMAX PLANCK GES ZUR FORDERUNGDE·Filed 2000·Granted Jun 14, 2005·3 cites·76 claims
- 0948US12338440B2Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereofIOMX THERAPEUTICS AG·Filed 2018·Granted Jun 24, 2025·0 cites·33 claims
- 1035US2020024347A1Or10h1 antigen binding proteins and uses thereofIOMX THERAPEUTICS AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sebastian Meier-Ewert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →